Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Parkinson's disease symptoms improve in Spheramine preclinical trial

May 4, 1998

Multiple mechanisms involved in neuroprotective effects of dexanabinol

May 4, 1998

Efficacy of racemic form of LY-300164 in clonic status epilepticus

May 4, 1998

Chiroscience submits NDA to FDA for Chirocaine

May 4, 1998

Bayer's potassium channel ligands for cognition disorders

May 4, 1998

Pfizer synthesizes dual ORL1 antagonists/opioid receptor agonists

May 4, 1998

First clinical results reported for NPS-1506

May 1, 1998

LY-300164 suppresses kindling-induced seizures in mice

May 1, 1998

Lamotrigine evaluated for the treatment of childhood autism

May 1, 1998

Beneficial effects of tolcapone on sleep disturbances in parkinsonian patients

May 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...